A few milestones worth knowing: 2021: Semaglutide 2.4 mg injection (Wegovy) was approved by the US FDA for weight management in June 2021
So, its really been a large collective effort from the scientific community based on our initial discovery, he said
Cutolo M, Wilder RL (2000) Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases
Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturers package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems